Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.
- Market Cap ₹ 457 Cr.
- Current Price ₹ 228
- High / Low ₹ 283 / 85.0
- Stock P/E 8.15
- Book Value ₹ 175
- Dividend Yield 0.66 %
- ROCE 22.3 %
- ROE 17.7 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 28.39% CAGR over last 5 years
Cons
- The company has delivered a poor growth of 7.75% over past five years.
- Promoter holding is low: 33.41%
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
80 | 67 | 100 | 103 | 84 | 79 | 97 | 113 | 99 | 78 | 104 | 126 | |
64 | 58 | 77 | 84 | 71 | 68 | 78 | 88 | 85 | 70 | 82 | 96 | |
Operating Profit | 16 | 10 | 23 | 19 | 14 | 11 | 19 | 25 | 13 | 9 | 22 | 30 |
OPM % | 20% | 14% | 23% | 19% | 16% | 14% | 20% | 22% | 13% | 11% | 21% | 24% |
Other Income | 3 | 1 | 2 | 4 | 0 | -1 | 1 | 3 | 3 | 4 | 2 | 1 |
Interest | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | -1 | 1 | -0 |
Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 16 | 8 | 23 | 20 | 11 | 8 | 18 | 25 | 13 | 12 | 21 | 29 |
Tax % | 29% | 15% | 29% | 26% | 19% | -8% | 29% | 24% | 16% | 22% | 29% | 27% |
Net Profit | 12 | 7 | 16 | 15 | 9 | 8 | 13 | 19 | 11 | 9 | 15 | 21 |
EPS in Rs | 5.79 | 3.42 | 8.04 | 7.50 | 4.58 | 4.25 | 6.34 | 9.46 | 5.46 | 4.47 | 7.63 | 10.46 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114 | 124 | 176 | 188 | 195 | 210 | 266 | 400 | 360 | 361 | 366 | 386 | 407 | |
104 | 113 | 167 | 174 | 179 | 190 | 240 | 359 | 313 | 308 | 299 | 321 | 333 | |
Operating Profit | 10 | 11 | 10 | 14 | 15 | 20 | 26 | 41 | 47 | 53 | 67 | 66 | 74 |
OPM % | 9% | 9% | 5% | 7% | 8% | 10% | 10% | 10% | 13% | 15% | 18% | 17% | 18% |
Other Income | -1 | 1 | 3 | 3 | 6 | 2 | 7 | 7 | 2 | 5 | 5 | 11 | 10 |
Interest | 2 | 3 | 5 | 8 | 8 | 7 | 8 | 10 | 7 | 5 | 4 | 2 | 1 |
Depreciation | 1 | 1 | 2 | 2 | 3 | 4 | 5 | 5 | 6 | 6 | 7 | 7 | 7 |
Profit before tax | 7 | 9 | 6 | 7 | 11 | 12 | 20 | 33 | 37 | 46 | 62 | 67 | 74 |
Tax % | 35% | 29% | 33% | 30% | 16% | 16% | 24% | 28% | 25% | 25% | 22% | 23% | |
Net Profit | 4 | 6 | 4 | 5 | 10 | 11 | 15 | 24 | 28 | 35 | 49 | 51 | 56 |
EPS in Rs | 5.40 | 2.56 | 3.14 | 5.92 | 6.53 | 9.20 | 14.52 | 14.06 | 17.31 | 24.36 | 25.72 | 28.02 | |
Dividend Payout % | 21% | 22% | 23% | 19% | 10% | 9% | 11% | 7% | 9% | 9% | 6% | 6% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 8% |
3 Years: | 2% |
TTM: | 9% |
Compounded Profit Growth | |
---|---|
10 Years: | 24% |
5 Years: | 28% |
3 Years: | 22% |
TTM: | 14% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 4% |
3 Years: | -5% |
1 Year: | 13% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 18% |
3 Years: | 18% |
Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8 | 11 | 16 | 16 | 16 | 16 | 16 | 16 | 20 | 20 | 20 | 20 | 20 | |
Reserves | 28 | 42 | 60 | 64 | 73 | 82 | 95 | 117 | 172 | 204 | 249 | 293 | 329 |
Borrowings | 16 | 27 | 44 | 65 | 76 | 68 | 76 | 78 | 64 | 61 | 34 | 5 | 18 |
22 | 31 | 44 | 66 | 72 | 93 | 70 | 64 | 48 | 62 | 63 | 71 | 81 | |
Total Liabilities | 73 | 111 | 165 | 212 | 237 | 260 | 258 | 275 | 305 | 347 | 366 | 389 | 448 |
17 | 21 | 28 | 38 | 65 | 65 | 66 | 98 | 103 | 117 | 121 | 123 | 120 | |
CWIP | 0 | 1 | 4 | 14 | 2 | 2 | 3 | 3 | 7 | 0 | 2 | 0 | 0 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 11 | 18 | 34 | 73 |
56 | 89 | 133 | 161 | 169 | 192 | 190 | 174 | 186 | 219 | 225 | 232 | 256 | |
Total Assets | 73 | 111 | 165 | 212 | 237 | 260 | 258 | 275 | 305 | 347 | 366 | 389 | 448 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2 | -11 | -34 | 12 | -16 | 5 | 25 | 45 | 25 | 27 | 53 | 75 | |
-4 | -6 | -11 | -27 | -16 | 1 | 7 | -42 | -25 | -12 | -18 | -31 | |
3 | 25 | 45 | 16 | 29 | -11 | -32 | -3 | 0 | -11 | -36 | -38 | |
Net Cash Flow | 1 | 9 | -0 | 1 | -3 | -4 | -1 | -0 | -0 | 3 | -1 | 7 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 17% | 10% | 10% | 11% | 12% | 16% | 22% | 19% | 19% | 23% | 22% | |
Debtor Days | 74 | 92 | 83 | 127 | 140 | 154 | 163 | 73 | 92 | 111 | 122 | 96 |
Inventory Turnover | 3.85 | 4.33 | 5.20 | 6.52 | 6.63 | 8.05 | 11.49 | 6.90 | 4.82 | 4.47 | 4.57 |
Documents
Add documentRecent announcements
- Shareholding for the Period Ended December 31, 2020 11 Jan
- Statement Of Investor Complaints For The Quarter Ended December 2020 11 Jan
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1 Jan
- Closure of Trading Window 31 Dec
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 29 Dec
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse